• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阈值之上,旅程之外:5-羟色胺受体在致幻剂诱导的神经可塑性和抗抑郁作用中的作用

Above the threshold, beyond the trip: the role of the 5-HT receptor in psychedelic-induced neuroplasticity and antidepressant effects.

作者信息

Drewko Adam J, Habets Ron L P, Brunt Tibor M

机构信息

Molecular and Biophysical Life Sciences programme, Undergraduate School, Faculty of Science, Utrecht University, Utrecht, The Netherlands.

PhD, Cell Biology, Neurobiology and Biophysics, Department of Biology, Faculty of Science, Utrecht University, Utrecht, The Netherlands.

出版信息

Mol Psychiatry. 2025 Aug 23. doi: 10.1038/s41380-025-03169-9.

DOI:10.1038/s41380-025-03169-9
PMID:40849544
Abstract

Serotonergic psychedelics, including the recreationally used psilocybin and LSD, have become promising therapeutic agents for the treatment of treatment-resistant depression. While it is generally agreed that they exhibit their antidepressant effects by inducing rapid and sustained neuroplasticity, the molecular mechanisms responsible are widely debated. In particular, the role of the serotonin 5-HT receptor, known to mediate the hallucinogenic effects of psychedelics, is under scrutiny. However, many studies remain in conflict on whether action at the receptor is also required for neuroplastic effects. In this narrative review, we examine the available evidence for the involvement of the 5-HT receptor in neuroplasticity induction and the possibly antidepressant effects of psychedelics. Firstly, we review the role of decreased neuroplasticity in depression, the evidence for dendrito-, spino- and synaptogenesis promotion by psychedelics, and for its possible regional selectivity. We then discuss the current knowledge on psychedelic action at the 5-HT receptor, including its role in promoting hallucinogenic effects. Finally, we critically assess the studies testing the necessity for 5-HT signalling for neuroplastic effects and present a model of molecular mechanisms responsible for psychedelic-induced neuroplasticity.

摘要

血清素能迷幻剂,包括用于消遣的裸盖菇素和麦角酸二乙酰胺(LSD),已成为治疗难治性抑郁症的有前景的治疗药物。虽然人们普遍认为它们通过诱导快速且持续的神经可塑性来发挥抗抑郁作用,但相关的分子机制仍存在广泛争议。特别是,已知介导迷幻剂致幻作用的血清素5-羟色胺(5-HT)受体的作用正在受到审查。然而,关于受体作用对于神经可塑性效应是否也是必需的,许多研究仍存在冲突。在这篇叙述性综述中,我们审视了5-HT受体参与神经可塑性诱导以及迷幻剂可能的抗抑郁作用的现有证据。首先,我们回顾神经可塑性降低在抑郁症中的作用、迷幻剂促进树突、棘突和突触形成的证据及其可能的区域选择性。然后,我们讨论目前关于迷幻剂作用于5-HT受体的知识,包括其在促进致幻作用中的作用。最后,我们批判性地评估测试5-HT信号传导对于神经可塑性效应必要性的研究,并提出一个负责迷幻剂诱导神经可塑性的分子机制模型。

相似文献

1
Above the threshold, beyond the trip: the role of the 5-HT receptor in psychedelic-induced neuroplasticity and antidepressant effects.阈值之上,旅程之外:5-羟色胺受体在致幻剂诱导的神经可塑性和抗抑郁作用中的作用
Mol Psychiatry. 2025 Aug 23. doi: 10.1038/s41380-025-03169-9.
2
Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.致幻剂辅助治疗对患有危及生命疾病的人群的焦虑、抑郁和存在性困扰的治疗作用。
Cochrane Database Syst Rev. 2024 Sep 12;9(9):CD015383. doi: 10.1002/14651858.CD015383.pub2.
3
From molecules to meaning: unpacking the antidepressant mechanisms of psychedelic drugs.从分子到意义:解析迷幻药物的抗抑郁机制
Expert Rev Clin Pharmacol. 2025 May;18(5):263-280. doi: 10.1080/17512433.2025.2515866. Epub 2025 Jun 11.
4
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
5
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
6
Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.裸盖菇素作为快速起效的变革性抗抑郁药:药理特性与分子机制
Fundam Clin Pharmacol. 2025 Aug;39(4):e70038. doi: 10.1111/fcp.70038.
7
Psychedelic use in individuals living with eating disorders or disordered eating: findings from the international MED-FED survey.饮食失调或进食紊乱个体使用迷幻剂的情况:国际MED-FED调查结果
J Eat Disord. 2025 Jul 24;13(1):152. doi: 10.1186/s40337-025-01328-5.
8
Structural pharmacology and therapeutic potential of 5-methoxytryptamines.5-甲氧基色胺的结构药理学和治疗潜力。
Nature. 2024 Jun;630(8015):237-246. doi: 10.1038/s41586-024-07403-2. Epub 2024 May 8.
9
Antidepressant treatment for postnatal depression.产后抑郁症的抗抑郁治疗。
Cochrane Database Syst Rev. 2014 Sep 11;2014(9):CD002018. doi: 10.1002/14651858.CD002018.pub2.
10
Are the LSD-analogs lisuride and ergotamine examples of non-hallucinogenic serotonin 5-HT2A receptor agonists?麦角酰二乙胺类似物利苏瑞ide和麦角胺是非致幻性血清素5-HT2A受体激动剂的例子吗?
J Psychopharmacol. 2025 Sep;39(9):889-895. doi: 10.1177/02698811251330741. Epub 2025 May 5.

本文引用的文献

1
Ketanserin exhibits dose- and concentration-proportional serotonin 2A receptor occupancy in healthy individuals: Relevance for psychedelic research.在健康个体中,酮色林表现出剂量和浓度与 5-羟色胺 2A 受体占有率呈比例关系:与致幻研究相关。
Eur Neuropsychopharmacol. 2024 Nov;88:43-48. doi: 10.1016/j.euroneuro.2024.07.003. Epub 2024 Aug 9.
2
The effect of antidepressant treatment on blood BDNF levels in depressed patients: A review and methodological recommendations for assessment of BDNF in blood.抗抑郁治疗对抑郁症患者血液脑源性神经营养因子水平的影响:血液脑源性神经营养因子评估的综述和方法学建议。
Eur Neuropsychopharmacol. 2024 Oct;87:35-55. doi: 10.1016/j.euroneuro.2024.06.008. Epub 2024 Jul 29.
3
Comparing the effect of fluoxetine, escitalopram, and sertraline, on the level of BDNF and depression in preclinical and clinical studies: a systematic review.
比较氟西汀、艾司西酞普兰和舍曲林在临床前和临床研究中对 BDNF 水平和抑郁的影响:系统评价。
Eur J Clin Pharmacol. 2024 Jul;80(7):983-1016. doi: 10.1007/s00228-024-03680-y. Epub 2024 Apr 1.
4
Comparative Pharmacological Effects of Lisuride and Lysergic Acid Diethylamide Revisited.重新审视利苏瑞ide与麦角酸二乙酰胺的比较药理作用。
ACS Pharmacol Transl Sci. 2024 Feb 5;7(3):641-653. doi: 10.1021/acsptsci.3c00192. eCollection 2024 Mar 8.
5
Identification of 5-HT receptor signaling pathways associated with psychedelic potential.鉴定与致幻潜力相关的 5-HT 受体信号通路。
Nat Commun. 2023 Dec 15;14(1):8221. doi: 10.1038/s41467-023-44016-1.
6
Psychedelics promote plasticity by directly binding to BDNF receptor TrkB.迷幻剂通过直接与脑源性神经营养因子受体 TrkB 结合来促进可塑性。
Nat Neurosci. 2023 Jun;26(6):1032-1041. doi: 10.1038/s41593-023-01316-5. Epub 2023 Jun 5.
7
Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants.静脉注射 DMT 在健康参与者中随机安慰剂对照研究的急性效应。
Transl Psychiatry. 2023 May 23;13(1):172. doi: 10.1038/s41398-023-02477-4.
8
The crosstalk between 5-HTR and mGluR2 in schizophrenia.精神分裂症中 5-HTR 与 mGluR2 的串扰。
Neuropharmacology. 2023 Jun 1;230:109489. doi: 10.1016/j.neuropharm.2023.109489. Epub 2023 Mar 6.
9
A non-hallucinogenic LSD analog with therapeutic potential for mood disorders.一种具有治疗情绪障碍潜力的非致幻 LSD 类似物。
Cell Rep. 2023 Mar 28;42(3):112203. doi: 10.1016/j.celrep.2023.112203. Epub 2023 Mar 6.
10
Shared and Distinct Brain Regions Targeted for Immediate Early Gene Expression by Ketamine and Psilocybin.氯胺酮和裸盖菇素激活即时早期基因表达的共享和特异脑区。
ACS Chem Neurosci. 2023 Feb 1;14(3):468-480. doi: 10.1021/acschemneuro.2c00637. Epub 2023 Jan 11.